BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG (BIOCEUTICAL INNOVATIONS) BIOCEUTICAL INNOVATIONS From Erdal Can Alkoclar WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS,… Metadata quality: Metadata quality: Data description filled Files documented License filled Update frequency not followed File formats are closed Temporal coverage not set Spatial coverage not set All files are available Learn more about this indicator Metadata quality: 56.0% Updated on May 17, 2020 Creative Commons Attribution 4.0 0 reuses 0 favorites
A Neurotrophic & Nootropic Formulation with BDNF and NGF mRNA Expression Enhancement Features for the Treatment of Neurological Damage & Development Disorders (BDNF NGF Neurotrophin) BDNF NGF Neurotrophin From Erdal Can Alkoclar A Neurotrophic and Nootropic Formulation consisting of a Pro-Somathropic Dioscin Analouge with increased systemic duration due to prolonged half-life, a Gymnemic Acid Analouge with BDNF NGF and Neurotrophin B3 mRNA Expression Enhancing Properties. Formulation may serve as an adjuvant curative… Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are closed Temporal coverage not set Spatial coverage not set All files are available Learn more about this indicator Metadata quality: 44.0% Updated on April 23, 2020 Creative Commons Attribution Share-Alike 4.0 0 reuses 0 favorites
